Malignant neoplasm of prostate Clinical Trials

262 clinical trials for Malignant neoplasm of prostate across international registries, including 85 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

Evaluation of training offers within the framework of the Center for Competence Development in Cancer Self-Help (ZfK KSH) — RECRUITING
Evaluation of the long-term outcomes of adjuvant or salvage radiotherapy after radical prostatectomy with or without inclusion of the lymphatic drainage area — RECRUITING
Search for exosomal biomarkers for urological tumors — RECRUITING
Navigation, outcomes and quality-of-life in prostate cancer patients undergoing PSMA-targeted surgery — RECRUITING
Early Prostate cancer recurrence with PSMA PET positive unilateral pelvic lesion(s): is one-sided salvage extended lymph node dissection enough? — RECRUITING
Dynamic Attribution of Hematologic Worsening Following ¹⁷⁷Lu-PSMA-617 Therapy in Patients with Bone-Metastatic mCRPC: A Multicenter Retrospective Cohort Study — RECRUITING
Prostate bed irradiation with alternative radio-oncological approaches — RECRUITING
MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA) — RECRUITING · PHASE2
PROSTAGOAL: Physical and Psychosocial Effects of a Structured Recreational Football Exercise Program in Patients with Prostate Cancer Undergoing Long-Term Antiandrogen Therapy — RECRUITING
Artificial Intelligence RIsk Stratification for Skeletal-Related Events — RECRUITING
Secure Evaluation of Anastomotic Leakage in Robotic Prostatectomy: a prospective, randomized, interventional comparison — RECRUITING
Feasibility study on the implementation of the new prostate cancer screening recommendation in Germany: PSA measurement using capillary blood sampling (PRO-KAP) — RECRUITING
Micro-Ultrasound for Extracapsular Extension Detection in Prostate Cancer: A Multicenter Reader Study — RECRUITING
Stereotactic radiotherapy of localized prostate cancer with daily online adaptive radiotherapy planning: a single-arm prospective interventional observational study (PCa SBRT Study) — RECRUITING
Molecular Fingerprinting in Cancer Detection — RECRUITING
Establishment of a prehabilitation process for patients with prostate cancer prior to curatively intended radical prostatectomy - an exploratory, prospective, controlled intervention study. — RECRUITING
Prospects of postoperative prostate cancer adaptive radiation therapy — RECRUITING
Characterisation of tumour heterogeneity and identification of adaptive resistance mechanisms of metastatic castration-resistant prostate carcinoma — RECRUITING
Characterization of the ALDH1A1/MMP11 pathway as a potential biomarker and regulator of prostate cancer progression and metastases — RECRUITING
Diagnostic Value of an AI-Based Software Solution for the Automated Classification of Lesions in Prostate MRI — RECRUITING
STereotActic Body Radiotherapy and 177Lutetium PSMA in Locally Advanced Prostate Cancer — RECRUITING · PHASE1
Tumor sink effect in patients with metastatic castration-resistant prostate cancer undergoing 177Lu-PSMA radioligand therapy — RECRUITING
Prostate Cancer Outcomes – Compare & Reduce Variation in Prostate Cancer Centers certified by the German Cancer Society; subproject MID-EPIC-D — RECRUITING
Proton therapy of prostate cancer: Prospective evaluation of effectiveness and side effects with standard clinical doses — RECRUITING
Characterization of venous return and perfusion of the lower extremities during anesthesia for a DaVinci surgery in steep Trendelenburg position — RECRUITING
The patient perspective: Therapy satisfaction and burden of prostate cancer patients receiving lutetium (177Lu) vipivotide tetraxetan radioligand therapy compared to patients receiving second-line chemotherapy with cabazitaxel — RECRUITING
Ultra-hypofractionated radiosurgery for localised prostate carcinoma — RECRUITING
HDR monotherapy for locally confined prostate cancer. — RECRUITING
Prospective randomised study of different surgical techniques to prevent postoperative lymphoceles after robot-assisted laparoscopic radical prostatectomy and their impact on peri- and postoperative morbidity and quality of life — RECRUITING
PROstate CAncer Real World Evidence Registry: RECURRENT AND METASTATIC PROSTATE CANCER — RECRUITING
Fluorescence-guided pelvic lymphadenectomy in prostate cancer: Restrospective analysis of diagnostic accuracy and oncologic outcomes — RECRUITING
Biodosimetry compared to physical dosimetry in nuclear medicine imaging and radionuclide therapies — RECRUITING
REDUCE – Reduced radiological and biopsy diagnostics in the primary diagnosis of prostate cancer: A prospective randomized non-inferiority intervention study comparing target plus systematic biopsy versus target plus peri-sensional biopsy — RECRUITING
Psychosocial outcomes of risk-adapted prevention for familial and genetic prostate cancer predisposition (ProFam-Psych) — RECRUITING
Clinical implementation and real-world outcomes of single-port robot-assisted laparoscopic procedures at a university medical centre — RECRUITING
GUARDIANS-Registry (GenitoUrinary Academic Research Development Initiative and Network) — RECRUITING
Implementation and evaluation of mobile health tools for personalised follow-up of patients in radiation therapy for prostate cancer — RECRUITING
Non-interventional, prospective health services research study on the course of testosterone levels during androgen deprivation therapy (ADT) with LHRH analogues (3-month depot). — RECRUITING
Improvement of the quality of care through standardized documentation — RECRUITING
Detection of clinically significant prostate cancer using novel diffusion-weighted MRI protocols in correlation with extended histopathological workup — RECRUITING
Late PET/CT acquisition for improved tissue characterization and assessment of treatment response: prospective data collection in clinically indicated examinations in oncology. — RECRUITING
PSMA-PET/CT analysis using convolutional neural networks for PSA-based prediction of a therapeutic response in patients with metastatic castration-resistant prostate cancer (mCRPC) to 177Lu-PSMA radioligand therapy — RECRUITING
Feasibility of focal treatment of localized prostate cancer with MRI / TRUS image fusion using the Focal One — RECRUITING
Observational study of therapy with High Intensive Focused Ultrasound (HIFU) at Prostate Cancer — RECRUITING
Healthcare-Reality in Urological Oncology: Determining the actual implementation of decisions made by the Urological Tumor Board and identifying reasons for inadequate therapy implementation — RECRUITING
Microstructure modelling using enhanced diffusion-weighted magnetic resonance imaging for non-invasive prostate cancer diagnostics - a feasibility study — RECRUITING
VONKO-017: ‘Characteristics, treatment patterns and survival of individuals with prostate cancer - including metastatic hormone-sensitive prostate cancer (mHSPC) and metastatic castration-resistant prostate cancer (mCRPC) - a study based on cancer registry data’ — RECRUITING
Analysis of tumor DNA markers in the plasma of cancer patients by liquid biopsy — RECRUITING
Focal laser ablation (FLA) for the focal treatment of localized prostate cancer — RECRUITING
Molecular biological and cellular characterization of urological tumours tumors for the investigation of tumorigenesis, metastasis and therapy response response to therapy, as well as establishment of an organoid and biobank of urological tumors — RECRUITING

Refine this search